These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34029643)

  • 1. The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis.
    Chang WI; Kim BH; Kang HC; Kim K; Lee KH; Oh DY; Kim H; Kwon W; Jang JY; Chie EK
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):395-404. PubMed ID: 34029643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
    Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer.
    Kim SW; Noh OK; Kim JH; Chun M; Oh YT; Kang SY; Lee HW; Park RW; Yoon D
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1161-1167. PubMed ID: 28447209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients.
    Park Y; Kim K; Paik JH; Chie EK; Jang JY; Kim SW; Oh DY
    Eur J Surg Oncol; 2018 May; 44(5):638-643. PubMed ID: 29422250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution.
    Kim BH; Kim K; Chie EK; Kwon J; Jang JY; Kim SW; Oh DY; Bang YJ
    Cancer Res Treat; 2017 Apr; 49(2):473-483. PubMed ID: 27554480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?
    Park HJ; Kim K; Paik JH; Chie EK; Kim S; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2016 Jun; 18(6):625-31. PubMed ID: 26459257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):81-7. PubMed ID: 22789492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients.
    Im JH; Seong J; Lee IJ; Park JS; Yoon DS; Kim KS; Lee WJ; Park KR
    Cancer Res Treat; 2016 Apr; 48(2):583-95. PubMed ID: 26323644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer.
    Kim BH; Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
    Am J Clin Oncol; 2017 Apr; 40(2):158-162. PubMed ID: 25171299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814).
    Park Y; Kim TH; Kim K; Yu JI; Jung W; Seong J; Kim WC; Choi JH; Chang AR; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Chie EK
    Cancer Res Treat; 2024 Jan; 56(1):272-279. PubMed ID: 37536713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.
    Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
    World J Gastroenterol; 2013 Mar; 19(9):1438-43. PubMed ID: 23539485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.
    Borghero Y; Crane CH; Szklaruk J; Oyarzo M; Curley S; Pisters PW; Evans D; Abdalla EK; Thomas MB; Das P; Wistuba II; Krishnan S; Vauthey JN
    Ann Surg Oncol; 2008 Nov; 15(11):3147-56. PubMed ID: 18754070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
    Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
    Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14).
    Kim K; Yu JI; Jung W; Kim TH; Seong J; Kim WC; Choi JH; Park Y; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Heo JS; Park JO; Jang JY; Oh DY; Woo SM; Lee WJ; Chie EK
    Eur J Cancer; 2021 Nov; 157():31-39. PubMed ID: 34474218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.
    Kim BH; Kim K; Chie EK; Kwon J; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    J Gastrointest Surg; 2015 Oct; 19(10):1833-41. PubMed ID: 26239516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.
    Lim YJ; Koh J; Kim K; Chie EK; Kim B; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ; Ha SW
    Radiother Oncol; 2015 Oct; 117(1):165-70. PubMed ID: 26235847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for recurrent extrahepatic bile duct cancer.
    Koh M; Park JH; Yoo C; Yoon SM; Jung J; Ryoo BY; Chang HM; Kim KP; Jeong JH; Kim JH
    PLoS One; 2021; 16(6):e0253285. PubMed ID: 34133471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of adjuvant radiotherapy versus chemoradiotherapy in patients with salivary gland tumors.
    Aral İP; İnan GA; Gökçe E; Gani Z; Ergün D; Arslan N; Akinci MB; Tezcan Y
    J Cancer Res Ther; 2024 Apr; 20(3):850-857. PubMed ID: 38261449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.